OFM

Omega Fund Management Portfolio holdings

AUM $154M
This Quarter Return
-30.64%
1 Year Return
-32.78%
3 Year Return
+82.35%
5 Year Return
+29.08%
10 Year Return
+90.46%
AUM
$135M
AUM Growth
+$135M
Cap. Flow
-$1.02M
Cap. Flow %
-0.76%
Top 10 Hldgs %
96.04%
Holding
14
New
–
Increased
1
Reduced
2
Closed
–

Top Buys

1
TBIO
Translate Bio, Inc. Common Stock
TBIO
$15

Top Sells

1
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
$602K
2
KZR icon
Kezar Life Sciences
KZR
$417K

Sector Composition

1 Healthcare 98.68%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
REPL icon
1
Replimune Group
REPL
$422M
$51M 37.84% 5,103,455 – –
TBIO
2
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$18.3M 13.55% 2,437,603 +2 +0% +$15
KZR icon
3
Kezar Life Sciences
KZR
$28.9M
$15.9M 11.82% 675,623 -17,649 -3% -$417K
PRTK
4
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$13.3M 9.89% 2,600,410 – –
OBSV
5
DELISTED
ObsEva SA Ordinary Shares
OBSV
$12.7M 9.38% 999,364 – –
FGEN icon
6
FibroGen
FGEN
$47.8M
$6.05M 4.48% 130,646 – –
CBAY
7
DELISTED
Cymabay Therapeutics
CBAY
$4.34M 3.22% 551,477 – –
CDTX icon
8
Cidara Therapeutics
CDTX
$1.66B
$3.55M 2.63% 1,508,794 – –
EPIX icon
9
ESSA Pharma
EPIX
$11.4M
$2.28M 1.69% 1,084,848 – –
PVLA
10
Palvella Therapeutics, Inc. Common Stock
PVLA
$599M
$2.07M 1.53% 778,230 – –
DRNA
11
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$1.79M 1.32% 167,157 -56,300 -25% -$602K
JNCE
12
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$1.79M 1.32% 529,965 – –
SNNA
13
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
$1.76M 1.3% 758,610 – –
EGLT
14
DELISTED
Egalet Corporation
EGLT
$7K 0.01% 2,889,926 – –